Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL

Por Offner, Fritz, Samoilova, Olga, Osmanov, Evgenii, Eom, Hyeon-Seok, Topp, Max S., Raposo, João, Pavlov, Viacheslav, Ricci, Deborah, Chaturvedi, Shalini, Zhu, Eugene, van de Velde, Helgi, Enny, Christopher, Rizo, Aleksandra, Ferhanoglu, Burhan
Publicado no Blood (2015)